Status:
COMPLETED
A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis
Lead Sponsor:
Kowa Research Institute, Inc.
Conditions:
Atherosclerosis
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of K-604 for the treatment of atherosclerosis.
Eligibility Criteria
Inclusion
- moderate carotid artery stenosis
Exclusion
- history of arteritis
- heavily calcified plaque
- uncontrolled hypertension
- poorly controlled diabetes
- hypercholesterolemia
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2011
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT00851500
Start Date
February 1 2009
End Date
August 1 2011
Last Update
August 17 2011
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Chandler, Arizona, United States
2
Litchfield Park, Arizona, United States
3
Phoenix, Arizona, United States
4
Los Angeles, California, United States